sabarubicin has been researched along with ketobemidone in 1 studies
| Studies (sabarubicin) | Trials (sabarubicin) | Recent Studies (post-2010) (sabarubicin) | Studies (ketobemidone) | Trials (ketobemidone) | Recent Studies (post-2010) (ketobemidone) |
|---|---|---|---|---|---|
| 29 | 5 | 4 | 102 | 27 | 6 |
| Protein | Taxonomy | sabarubicin (IC50) | ketobemidone (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 7 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 7 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 7 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 7 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 7 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for sabarubicin and ketobemidone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |